Tinnitus, also known as Zumitus, is defined as the sound perception when there is no sound source. The purpose can be transmitted or subjective sounds or sounds created by the body, created by an abnormal neural activity. "Objective tinnitus is rare, but the subjective is a disorder that often occurs, which increases the effect by age, from 20% to 30%, between 50% and 50%," says Dr. Bartholomé Scola, Director of the Vithas International Voice and Ear Nose-Anger Unit, is a Vithas healthcare center, with 19 hospitals and 29 medical centers in Spain.
As a specialization, there are numerous risk factors for the dangers of subjectivity, such as hearing loss, for any reason, age, acute traumatism, infectious diseases, ototoxic antibiotics and cystostatics.
In relation to the severity of the tinnitus, it is highly variable and there is no objective assessment to quantify the level of involvement beyond the person's assessment. "Patients suffer from discomfort when they occur in silent environments, but sometimes they can change their quality of life, their ability to work intellectually, or sleep difficulties," says Dr. Scola.
Currently, the tinnitus production mechanism is not known, and there are probably a number of associated pathophysiology. "That is why it is not possible to establish a single vision, and each case should be treated in a personalized way, there are several management options that proved to be effective in achieving better tolerance and reducing discomfort."
As Dr. Scola explains, there are different ways of managing cancer. "Sometimes, the treatment of an underlying condition that causes hearing loss will alleviate tinnitus, such as removal of the heponia or foreign body."
However, these quick ways to relieve pain is not possible for most of the time. In many other cases, managing possible options with hearing aids allows 50% of patients to improve auditory loss; the noisy sounds of the creators; Tinnitus Retraining Therapy (TRT), combining therapeutic counseling with sound therapy and pharmacological treatments, always individually.
In addition, clinical trials for localization of insulin are being developed in patients with renal and insulin cancer patients. Likewise, the mechanical magnetic stimulation is in the phase of research.
Today, however, although it is not a healing treatment, a personalized perspective improves the quality of life of the patient.